TP53 and neoplasm: The known differences between mouse and human cancer biology, including differential telomere length, distinct utilization of p16INK4a-RB versus p53 signalling and different sensitivity to anti-tumour drugs, however, have limited the degree to which insights derived from mouse models can be directly translated to human applications14, 15, 16.